ArticleAmerican journal of cancer research2016

Celecoxib-erlotinib combination delays growth and inhibits angiogenesis in EGFR-mutated lung cancer.

Yi Xiao Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.